Clinical trial

Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial

NCT07599163

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-08

PhaseNA

Study timeline

Study start (estimated)2026-06-08Date precision: day

Registry last updated2026-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lung Cancerunresolved

Neoadjuvant Therapyunresolved

Paclitaxelunresolved

Interventions

Paclitaxel Oral SolutionDRUG

Sponsors & collaborators

Shanghai Pulmonary Hospital, Shanghai, Chinalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07599163 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.